AQST vs AZO · rev $28.3M vs P/E 21, rev $18.94B
Aquestive Therapeutics Inc (AQST) versus AutoZone Inc (AZO) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
AutoZone Inc (AZO) is a auto parts company listed on NYSE.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported AZO revenue for 2025-08-30 was $18.94B. Net income was $2.50B. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
AQST currently screens at market cap $493.0M. AZO currently screens at market cap $50.08B and trailing P/E 21.0.
Not investment advice. Open the AQST and AZO stock pages for the full models.
Not investment advice.